| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
cytokine receptor like factor 2 | 0.615 | 0.538 | 3.3E-07 |
|
group | 0.320 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2003 | 2019 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2020 | ||||||||
|
lysine demethylase 6A | 0.498 | 0.769 | 1.00 |
|
group | 0.600 | None | 1.000 | 0 | 0 | 2009 | 2019 | ||||||||
|
SUZ12 polycomb repressive complex 2 subunit | 0.529 | 0.577 | 1.00 |
|
group | 0.360 | None | 1.000 | 0 | 0 | 2009 | 2015 | ||||||||
|
UDP glucuronosyltransferase family 1 member A1 | 0.464 | 0.769 | 3.3E-06 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1997 | 2019 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2004 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1988 | 2020 | ||||||||
|
colony stimulating factor 1 receptor | 0.448 | 0.808 | 0.13 |
|
group | 0.600 | None | 1.000 | 0 | 0 | 1992 | 2020 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1995 | 2019 | ||||||||
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
myogenic differentiation 1 | 0.569 | 0.654 | 0.15 |
|
group | 0.370 | None | 1.000 | 0 | 0 | 2001 | 2020 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1995 | 2020 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.988 | 0 | 0 | 1997 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.400 | None | 0.987 | 0 | 0 | 1994 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.400 | None | 0.986 | 0 | 0 | 1999 | 2020 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.984 | 0 | 0 | 1988 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 2002 | 2020 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 2001 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 1995 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.400 | None | 0.979 | 0 | 0 | 2003 | 2020 |